The Vanguard Group 13D and 13G filings for Standard BioTools Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-12 6:01 pm Unchanged |
2024-09-30 | 13G | Standard BioTools Inc. LAB |
The Vanguard Group | 17,292,092 4.650% |
0 (Unchanged) |
Filing |
| 2024-11-04 1:59 pm Purchase |
2024-09-30 | 13G | Standard BioTools Inc. LAB |
The Vanguard Group | 17,292,092 4.650% |
13,158,153 (+318.30%) |
Filing |
| 2024-02-13 5:14 pm Purchase |
2023-12-29 | 13G | Standard BioTools Inc. LAB |
The Vanguard Group | 4,133,939 5.210% |
177,971 (+4.50%) |
Filing |
| 2023-02-09 11:32 am Purchase |
2022-12-30 | 13G | Standard BioTools Inc. LAB |
The Vanguard Group | 3,955,968 4.990% |
88,297 (+2.28%) |
Filing |
| 2022-02-10 08:11 am Purchase |
2021-12-31 | 13G | Standard BioTools Inc. LAB |
The Vanguard Group | 3,867,671 5.060% |
391,361 (+11.26%) |
Filing |
| 2021-02-10 10:52 am Sale |
2020-12-31 | 13G | Standard BioTools Inc. LAB |
The Vanguard Group | 3,476,310 4.690% |
-933,466 (-21.17%) |
Filing |